Crystalline form of 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dio xo4-(trifluoromethyl)-1-(2H)-pyrimidinyl]-4fluoro-N- [(methyl-(1-methyl-ethyl)amino]sulphon yl]benzamide

Details for Australian Patent Application No. 2007306270 (hide)

Owner BASF SE

Inventors Michel, Alfred; Reinhard, Robert; Seitz, Werner; Zagar, Cyrill; Lohr, Sandra; Cox, Gerhard; Mayer, Guido; Schmidt, Thomas; Hamprecht, Gerhard; Wolf, Bernd; Gebhardt, Joachim; Sievernich, Bernd; Wevers, Jan Hendrik; Erk, Peter; Keil, Michael; Saxell, Heidi Emilia

Agent Watermark

Pub. Number AU-A-2007306270

PCT Pub. Number WO2008/043835

Priority 06122265.9 13.10.06 EP

Filing date 12 October 2007

Wipo publication date 17 April 2008

International Classifications

C07D 239/54 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A01N 43/48 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds - having rings with two nitrogen atoms as the only ring hetero atoms

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/043835 Priority application(s): WO2008/043835

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007306271-Hydrates of 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dio xo4-(trifluoro-methyl)-1-(2H)-pyrimidinyl]-4 -fluoro-N- [[methyl-(1-methylethyl)-amino]sulphon yl]benzamide

2007306266-Method and system for tracking medical products